ICTA Project Management En Abrege ICTA P.M
ICTA Project Management En Abrege ICTA P.M is recorded as a service provider in 9 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 9 of 9 trials · Latest update first
A Phase 1/2, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of IPH6501 in Patients with Relapsed and/or Refractory CD20-expressing Non-Hodgkin Lymphoma
Sponsor Innate Pharma
- Start (EU)
- Latest update
- Estimated end
A French multicenter Phase 4 open label extension study of long-term safety and efficacy in patients with Pompe disease who previously participated in avalglucosidase development studies in France
Sponsor Sanofi Winthrop Industrie
- Start (EU)
- Latest update
- Estimated end
- Not reported
Atezolizumab, Pertuzumab and Trastuzumab with chemotherapy as neoadjuvant treatment of HER2 positive early high-risk and locally advanced breast cancer (APTneo)
Sponsor Fondazione Michelangelo
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 1/2, Multicenter Study Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Single-Ascending Doses in Healthy Participants and Multiple-Ascending Doses and Proof-of-Concept in Participants with Cystic Fibrosis
Sponsor Recode Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
An open-label, phase 2 trial to evaluate the efficacy and safety of a single intravenous administration of GNT0003 (an adeno-associated viral vector expressing the UGT1A1 transgene) following imlifidase pre-treatment in participants aged 16 years and older with severe Crigler-Najjar syndrome requiring daily phototherapy and presenting pre-existing anti-AAV8 antibodies.
Sponsor Genethon
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 1/2a, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Healthy Volunteers and in Subjects with Chronic Hepatitis B Infection, Including Subjects with Chronic Hepatitis D Infection
Sponsor Bluejay Therapeutics Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Long-Term follow-up Study to evaluate safety and tolerability of olipudase alfa in patients who completed the DFI12712 or the LTS13632 Study in France - PTA17397
Sponsor Sanofi Winthrop Industrie
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase 1/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of hESC-derived RPE (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)) in patients with retinitis pigmentosa due to monogenic mutation
Sponsor Centre D'Etude Des Cellules Souches
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2a, Open-Label Multiple Dose Study Evaluating the Safety, Tolerability, and Pharmacodynamics of Imdusiran (AB-729) in Combination with Intermittent Dosing of Durvalumab, a PD-L1 Monoclonal Antibody, in Subjects with Chronic HBV Infection
Sponsor Arbutus Biopharma Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for ICTA Project Management En Abrege ICTA P.M?
The 2026-10-09 snapshot links ICTA Project Management En Abrege ICTA P.M to 9 distinct CTIS trials. Recorded services include Clinical monitoring, Regulatory services, Data management, Project management, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for ICTA Project Management En Abrege ICTA P.M?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to ICTA Project Management En Abrege ICTA P.M conducted?
The linked trials record locations in 10 countries, including France, Romania, Spain, Austria, Belgium. These are trial locations, not confirmed office locations or countries where ICTA Project Management En Abrege ICTA P.M delivered services.
What can this page tell me about ICTA Project Management En Abrege ICTA P.M's trial experience?
Browse 9 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under ICTA Project Management En Abrege ICTA P.M. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- ICTA Project Management En Abrege ICTA P.M.